Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion type Assertion NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_head.
- NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion description "[Based on these findings, we suggest that DCXR overexpression has the potential to be an additional useful biomarker for prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_provenance.
- NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion evidence source_evidence_literature NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_provenance.
- NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion SIO_000772 18086765 NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_provenance.
- NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion wasDerivedFrom befree-2016 NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_provenance.
- NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_assertion wasGeneratedBy ECO_0000203 NP645723.RAYV8b8UL5fGBbqPZhwqumxOhw1VGcKvTEEeC2mFOTW24130_provenance.